Welcome - Home - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Viewing report Order by Fax Printer Friendly PDF Brochure Send to Friend Enquire before Buying Electronic (PDF) Site License Commercializing Molecular Diagnostics: Products, Services, Companies and Global Market Takeda Pacific, July 2008, Pages: 175   Description     Table of Contents     Companies Mentioned        Enquire before Buying    Send to a Friend   This report is about the molecular diagnostics market, including systems, consumables and clinical lab services. These key medical products and services use technologies that can detect single or multiple genomic, protein, metabolomic or other ‘-omic’ biomarkers. The detailed study shows that molecular diagnostic companies are expecting continued strong growth. This report shows the major areas of this dynamic market landscape, including the various views of this growing multi-billion dollar market. The study sizes the market and projects the 5-year trend. The report charts the developments of more than 80 companies involved in this dynamic industry. This report discusses government regulatory initiatives to accelerate the approvals of emerging molecular diagnostics by integrating biomarkers and companion pharmacogenomic tests. Myriad, Veridex, Genomic Health, Agendia and others are gaining traction detecting cancers. Roche’s Affymetrix-based tests measure how patients respond to 30 or more currently marketed drugs. These products enable the emerging field of personalized medicine. The passing of the GINA law in the US might foster the growth of more molecular diagnostics, clinical lab services and other related genetic testing services. This study is full of interesting data and includes more than 43 figures and tables. The tables provide data about technologies, companies, product pipelines, partnerships and more. The study also has additional data such as the global incidence and prevalence of major diseases. The report analyzes partnering deals and includes several years of alliance and M&A data. Thirty-eight selected companies are profiled, with details including contact information, business and product overviews, alliances and patent or other financial details. This report would benefit people with job titles such as: CEO, VPs, Director of Business Development, Research Directors, Entrepreneurs, Venture Capitalists, Investment Planners, Research Scientists, Consultants or Industry Analysts. Customers who bought this item also bought Commercializing Molecular Diagnostics: Products, Services, Companies and Global Market Over-the-Counter Diagnostic Products World Markets Molecular Diagnostics: Transforming Pharmaceuticals, Impacting New Markets Molecular Diagnostics 2007: Technologies, Companies, Products, Applications and WW Outlook Molecular Diagnostics 2007: Technologies, Companies, Products, Applications and WW Outlook Biomarkers and Related Tests for Molecular Diagnostics and Pharma/ Biotech R&D -- Companies Products and WW Market, 2004-2009 High Growth Diagnostics: Technology and Market Analyses Global Corn Wet Milling industry Analysis & Review Starch, Sweetners & Co-products 2008

		Top of page

All rights reserved. � Copyright 2008 Research and Markets    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster